Oxford Ledge
Search
eXoZymes, Inc. (NASDAQ: EXOZ) is a $30M biotechnology company trading at $4.60. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:49 UTC.
eXoZymes develops technology to produce chemicals using artificially intelligent enzymes that operate outside living cells in bioreactors, rather than through traditional petrochemical or natural extraction methods. The company focuses on creating biosolutions to manufacture valuable compounds for pharmaceutical, nutraceutical, and biofuel markets by converting affordable feedstocks into specific chemical products.
Summarized from eXoZymes, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
| Quote | |
| Price | $4.60 |
| Market cap | $30M |
| Volume | 529 shares |
| Valuation | |
| Return on equity | 530.39% |
eXoZymes develops technology to produce chemicals using artificially intelligent enzymes that operate outside living cells in bioreactors, rather than through traditional petrochemical or natural extraction methods.
EXOZ trades at $4.60, as of 2026-10-11.
eXoZymes, Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-01. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:49 UTC. This page is also available as JSON at /api/data?ticker=EXOZ and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for EXOZ and 5,000+ tickers.
Create a free account — keep EXOZGET /api/data?ticker=EXOZ
This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt